Mechanisms of adenosine release in the developing and adult mouse hippocampus

Neurochemical Research

Volumn 27, Issue 9, 2002, Pages 911-918

  Saransaari, Pirjo ^a   Oja, Simo S ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Adenosine release; Glutamate receptors; Hippocampus; Slices; Superfusion; Taurine

Indexed keywords

4 ACETAMIDO 4' ISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; 4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; ADENOSINE; AMILORIDE; AMINOPHENAZONE; ANION CHANNEL; IONOTROPIC RECEPTOR AGONIST; METABOTROPIC RECEPTOR; RILUZOLE; TAURINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN SLICE; CELL DAMAGE; CONTROLLED STUDY; DEVELOPMENT; FEMALE; HIPPOCAMPUS; ISCHEMIA; MALE; MOUSE; NERVE CELL LESION; NERVOUS TISSUE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL;

ADENOSINE; ANIMALS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HIPPOCAMPUS; MALE; MICE; POTASSIUM CHANNELS; SODIUM CHANNELS;

ANIMALIA; HIPPOCAMPUS HIPPOCAMPUS;

EID: 0036744951     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020343631833     Document Type: Article

References (66)

1. Cunha, R. A. 2001. Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: Different roles, different sources and different receptors. Neurochem. Int. 38:107-125.
2. Latini, S. and Pedata, F. 2001. Adenosine in the central nervous system: Release mechanisms and extracellular concentrations. J. Neurochem. 79:463-484.
3. Haas, H. L. and Greene, R. W. 1988. Endogenous adenosine inhibits hippocampal CAI neurones: Further evidence from extra- and intracellular recording. Naunyn Schmiedeberg's Arch. Pharmacol. 337:561-565.
4. Psarropoulou, C., Kostopoulos, G., and Haas, H. L. 1990. An electrophysiological study of the ontogenesis of adenosine receptors in the CAI area of rat hippocampus. Dev. Brain Res. 55:147-150.
5. 1 receptors and their coupling to G proteins in the rat brain. Neuroscience 40:841-851.
6. Hagberg, H., Andersson, P., Lazarewicz, J., Jacobson, I., Butcher, S., and Sandberg, M. 1987. Extracellular adenosine, inosine, hypoxanthine, and xanthine in relation to tissue nucleotides and purines in rat striatum during transient ischemia. J. Neurochem. 49:227-231.
7. Phillis, J. W., Walter, G. A., O'Regan, M. H., and Stair, R. E. 1987. Increases in cerebral cortical perfusate adenosine and inosine concentrations during hypoxia and ischemia. J. Cereb. Blood Flow Metab. 7:679-686.
8. Rudolphi, K. A., Schubert, P., Parkinson, F. E., and Fredholm, B. B. 1992. Adenosine and brain ischemia. Cerebrovasc. Brain Metab. Rev. 4:346-369.
9. Dragunow, M. and Faull, R. L. 1988. Neuroprotective effects of adenosine. Trends Pharmacol. Sci. 9:193-194.
10. Deckert, J. and Gleiter, C. H. 1994. Adenosine: An endogenous neuroprotective metabolite and neuromodulator. J. Neural Transm. 43(Suppl.):23-31.
11. Saransaari, P. and Oja, S. S. 2000. Taurine and neural cell damage. Amino Acids 19:509-526.
12. Kontro, P. and Oja, S. S. 1987. Taurine and GABA release from mouse cerebral cortex slices: Potassium stimulation releases more taurine than GABA from developing brain. Dev. Brain Res. 37:277-291.
13. Huxtable, R. J. 1992. The physiological actions of taurine. Physiol. Rev. 72:101-163.
14. Sturman, J. A. 1993. Taurine in development. Physiol. Rev. 73:119-147.
15. Bouchard, R. and Fedida, D. 1995. Closed- and open-state binding of 4-aminopyridine to the cloned human potassium channel Kv1.5. J. Pharmacol. Exp. Ther. 275:864-876.
16. Doble, A. 1996. The pharmacology and mechanism of action of riluzole. Neurology 47:S233-S241.
17. Hamill, O. P. and McBride, D. W. Jr. 1996. The pharmacology of mechanogated membrane ion channels. Pharmacol. Rev. 48:231-252.
18. Saransaari, P. and Oja, S. S. 1994. Taurine release from mouse hippocampal slices: Effects of glutamatergic substances and hypoxia. Adv. Exp. Med. Biol. 359:279-287.
19. +- and glutamate-evoked release of endogenous adenosine from rat cortical slices. J Neurochem. 54:256-265.
20. Craig, C. G. and White, T. D. 1993. N-Methyl-D-aspartate- and non-N-methyl-D-aspartate-evoked adenosine release from rat cortical slices: Distinct purinergic sources and mechanisms of release. J. Neurochem. 60:1073-1080.
21. Latini, S., Pedata, F., and Pepeu, G. 1997. The contribution of different types of calcium channels to electrically-evoked adenosine release from rat hippocampal slices. Naunyn Schmiedeberg's Arch. Pharmacol. 355:250-255.
22. Hoehn, K. and White, T. D. 1990. Glutamate-evoked release of endogenous adenosine from rat cortical synaptosomes is mediated by glutamate uptake and not by receptors. J. Neurochem. 54:1716-1724.
23. Chen, Y., Graham, D. I., and Stone, T. W. 1992. Release of endogenous adenosine and its metabolites by the activation of NMDA receptors in the rat hippocampus in vivo. Br. J. Pharmacol. 106:632-638.
24. Korpi, E. R. and Oja, S. S. 1983. Characteristics of taurine release from cerebral cortex slices induced by sodium-deficient media. Brain Res. 289:197-204.
25. Parkinson, F. E., Rudolphi, K. A., and Fredholm, B. B. 1994. Propentofylline: A nucleoside transport inhibitor with neuroprotective effects in cerebral ischemia. Gen. Pharmacol. 25:1053-1058.
26. Sweeney, M. I. 1996. Adenosine release and uptake in cerebellar granule neurons both occur via an equilibrative nucleoside carrier that is modulated by G proteins. J. Neurochem. 67:81-88.
27. Oja, S. S. and Korpi, E. R. 1985. Amino acid transport. Pages 311-337, in Lajtha A. (ed.) Handbook of Neurochemistry, Vol. 5, 2nd ed. Plenum Press, New York.
28. Schousboe, A., Morán, J., and Pasantes-Morales, H. 1990. Potassium-stimulated release of taurine from cultured cerebellar granule cells is associated with cell swelling. J. Neurosci. Res. 27:71-77.
29. Saransaari, P. and Oja, S. S. 1999. Mechanisms of D-aspartate release under ischemic conditions in mouse hippocampal slices. Neurochem. Res. 24:1009-1016.
30. Delaney, S. M., Shepel, P. N., and Geiger, J. D. 1998. Levels of endogenous adenosine in rat striatum. I. Regulation by ionotropic glutamate receptors, nitric oxide and free radicals. J. Pharmacol. Exp. Ther. 285:561-567.
31. Craig, C. G. and White, T. D. 1993. NMDA-evoked adenosine release from rat cortex does not require the intermediate formation of nitric oxide. Neurosci. Lett. 159:167-169.
32. Craig, C. G., Temple, S. D., and White, T. D. 1994. Is cyclic AMP involved in excitatory amino acid-evoked adenosine release from rat cortical slices. Eur. J. Pharmacol. 269:79-85.
33. Szatkowski, M. and Attwell, D. 1994. Triggering and execution of neuronal death in brain ischemia: Two phases of glutamate release by different mechanisms. Trends Neurosci. 17:359-365.
34. Pin, J.-P. and Duvoisin, R. 1995. The metabotropic glutamate receptors: Structure and functions. Neuropharmacology 34:1-26.
35. Conn, P. J. and Pin, J.-P. 1997. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37:205-237.
36. Riedel, G. 1996. Function of metabotropic glutamate receptors in learning and memory. Trends Neurosci. 19:219-224.
37. Uyama, Y., Ishida, M., and Shinozaki, H., 1997. DCG-IV a potent metabotropic glutamate receptor agonist, as an NMDA receptor agonist in the rat cortical slice. Brain Res. 752:327-330.
38. Sánchez-Prieto, J., Budd, D. C., Herrero, I., Vázquez, E., and Nicholls, D. G., 1996. Presynaptic receptors and the control of glutamate exocytosis. Trends Neurosci. 19:235-239.
39. Cozzi, A., Attucci, S., Peruginelli, F., Marinozzi, M., Luneia, R., Pellicciari, R., and Moroni, F. 1997. Type 2 metabotropic glutamate (mGlu) receptors tonically inhibit transmitter release in rat caudate nucleus: In vivo studies with (2S,1′S,2′S,3′R)-2-(2′-carboxy-3′ -phenylcyclopropyl)glycine, a new potent and selective antagonist. Eur. J. Neurosci. 9:1350-1355.
40. Bruno, V., Battaglia, G., Copani, A., Giffard, R. G., Raciti, G., Shinozaki, H., and Nicoletti, F. 1995. Activation of class II or III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration. Eur. J. Neurosci. 7:1906-1913.
41. McDonald, J. W. and Johnston, M. V. 1990. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res. Rev. 15:41-70.
42. 3H]MK-801 binding in the embryonic and early postnatal rat CNS. Neurosci. Res. Commun. 19:145-152.
43. Pokorny, J. and Yamamoto, T. 1981. Postnatal ontogenesis of hippocampal CAI area in rats. I. Development of dendritic arborization in pyramidal neurons. Brain Res. Bull. 7:113-120.
44. Miller, L. P., Johnston, A. E., Gelhard, R. E., and Insel T. R. 1990. The ontogeny of excitatory amino acid receptors in the rat forebrain. II. Kainic acid receptors. Neuroscience 35:45-51.
45. 2A receptors in the rat hippocampus. Brain Res. 649:208-216.
46. Sebastiao, A. M., Stone, T. W., and Ribeiro, J. A. 1990. The inhibitory adenosine receptor at the neuromuscular junction and hippocampus of the rat: Antagonism by 1,3,8-substituted xanthines. Br. J. Pharmacol. 101:453-459.
47. Greene, R. W. and Haas, H. L. 1991. The electrophysiology of adenosine in the mammalian central nervous system. Prog. Neurobiol. 36:329-341.
48. 2 adenosine receptors in the rat hippocampus. Neurosci. Lett. 138:41-44.
49. Fredholm, B. B. and Dunwiddie, T. V. 1988. How does adenosine inhibit transmitter release? Trends Pharmacol. Sci. 9:130-134.
50. 2 receptors induces catalepsy. Neurosci. Lett. 130:162-164.
51. 2A receptor-mediated modulation of striatal GABA and ACh release. Br. J. Pharmacol. 113:43-48.
52. +-evoked glutamate release in vivo in young and aged rats. Neuroreport 10:687-691.
53. Greiger, J. D., LaBella, F. S., and Nagy, J. I. 1984. Ontogenesis of adenosine receptors in the central nervous system of the rat. Brain Res. 315:97-104.
54. 2A receptors in rat brain: Comparison with dopamine receptors. Neuroscience 80:1187-1207.
55. Morgan, P. F., Deckert, J., Nakajima, T., Daval, J. L., and Marangos, P. J. 1990. Late ontogenetic development of adenosine A1 receptor coupling to associated G-proteins in guinea pig cerebellum but not forebrain. Mol. Cell. Biol. 921:169-176.
56. Saransaari, P. and Oja, S. S. 1999. Characteristics of ischemia-induced taurine release in the developing mouse hippocampus. Neuroscience 94:949-954.
57. Kontro, P., Marnela, K.-M., and Oja, S. S. 1980. Free amino acids in the synaptosome and synaptic vesicle fractions of different bovine brain areas. Brain Res. 184:129-141.
58. Magnusson, K. R., Clements, J. R., Wu, J.-Y., and Beitz, A. J. 1989. Colocalization of taurine- and cysteine sulfinic acid decarboxylase-like immunoreactivity in the hippocampus of the rat. Synapse 4:55-69.
59. Saransaari, P. and Oja, S. S. 1998. Release of endogenous glutamate, aspartate, GABA and taurine from hippocampal slices from adult and developing mice under cell-damaging conditions. Neurochem. Res. 23:563-570.
60. Taber, K. H., Lin, C.-T., Liu, J.-W., Thalmann, R., and Wu, J.-Y. 1986. Taurine in hippocampus: localization and postsynaptic action. Brain Res. 386:113-121.
61. French, E. D., Vezzani, A., Whetsell, W. O. Jr., and Schwarcz, R. 1986. Antiexcitotoxic actions of taurine in the rat hippocampus studied in vivo and in vitro. Adv. Exp. Med. Biol. 203:349-362.
62. Trenkner, E. 1990. The role of taurine and glutamate during early postnatal cerebellar development of normal and weaver mutant mice. Adv. Exp. Med. Biol. 268:239-244.
63. Schurr, A., Tseng, M. T., West, C. A., and Rigor, B. M. 1987. Taurine improves the recovery of neuronal function following cerebral hypoxia: An in vitro study. Life Sci. 40:2059-2066.
64. Oja, S. S. and Kontro, P. 1983. Free amino acids in epilepsy: possible role of taurine. Acta Neurol. Scand. 67(Suppl. 93):5-20.
65. Saransaari, P. and Oja, S. S. 2000. Modulation of the ischemia-induced taurine release by adenosine receptors in the developing and adult mouse hippocampus. Neuroscience 97:425-430.
66. Saransaari, P. and Oja, S. S. 2002. Characterization of N-methyl-D-aspartate-evoked taurine release in the developing and adult mouse hippocampus. Amino Acids, in press.